[Clinical experience with long-term administration of "essential" phospholipids in chronic active hepatitis. Review of 3 double-blind studies].
The results from three double-blind studies, obtained after a 12-month treatment with Essentiale or placebo in patients (n = 85) with HBsAg positive or HBsAg negative chronic active hepatitis provide evidence of the clear improvement of the clinical and histological picture in the majority of the patients treated with Essentiale forte.
Ilic
V
V
University Clinical Center, Institute for Infectious and Tropical Diseases, Beograd, Yugoslavia.
Kordac
V
V
Alvarez
S Z
SZ
D004311:Double-Blind Method; D006509:Hepatitis B / Q000188:drug therapy*; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006801:Humans; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D010713:Phosphatidylcholines; C011246:essential 303 forte
Klinické zkusenosti s dlouhodobým podáváním "esenciálních" fosfolipidů u chronické aktivní hepatitidy. Prehled tri dvojitých slepých studií.